Immunic Inc. (IMUX) Tops Q3 EPS by 4c

Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.51), $0.04 better than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
• BlockchainK2 plans private placement to raise up to $130,000